XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos
PR91278
BEIJING, Aug. 25, 2021 /PRNewswire=KYODO JBN/ --
Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently
issued an honorary certificate to Beijing Applied Biological Technologies
(XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to support
Vientiane's efforts at epidemic prevention and control in 2021. At the same
time, the deputy director of the Vientiane's foreign affairs office, sent a
letter of thanks to XABT on behalf of the Vientiane Municipal Government and
Epidemic Prevention and Control Committee.
During the last coronavirus outbreak in Laos in April this year, XABT donated
5,040 Multiple Real Time PCR Kits for Detection of 2019-nCoV and provided full
technical service support to Vientiane to help the city control the spread of
the disease through in-depth international cooperation.
Virus knows no borders, but the worst of times reveals the best in people.
Since the outbreak of COVID-19, XABT has undertaken corporate social
responsibility with practical actions and donated nucleic acid detection and
extraction kits to Italy, Iran, Malaysia, Thailand, Peru and Bangladesh to
support their fights against the epidemic. The company will continue to make
positive contributions to continue the effort at controlling the epidemic
worldwide.
Nucleic acid detection is an important testing and screening method for
2019-nCoV used by the World Health Organization (WHO) and national health
authorities. XABT, among all the companies that have obtained the registration
certificate from the National Medical Products Administration of China for the
coronavirus nucleic acid detection reagent, is one of the few high-tech
companies producing the rapid detection technology covering three genes,
ORF1ab, N and E. The company's 2019-nCoV nucleic acid detection kit
(fluorescence PCR method) can achieve up to 99.9% accuracy due to the specific
binding at the molecular level and was included in the WHO Emergency Use
Listing in May 2020. The company has received the ISO13485 system
certification, and its products, all of which conform to the EU's CE
certification standards, are being adopted by more and more countries as a tool
to control and prevent the further spread of the virus as well as being
recognized as the most effective solution by more and more organizations.
For more information:
Company website: http://www.x-abt.com/en/
LinkedIn(
https://www.linkedin.com/company/beijing-applied-biological-technologies-co-ltd/?viewAsMember=true),
Facebook(
https://www.facebook.com/Beijing-Applied-Biological-Technologies-Co-Ltd-105959585091102),
YouTube(
SOURCE: XABT
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=398967
Link: http://asianetnews.net/view-attachment?attach-id=398970
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。